Latest Share Chat

DIRECTOR DEALINGS: Hikma Directors Up Stake As Darhold Acquires Shares

Thu, 15th Sep 2016 15:55

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Darhold Ltd, a company in which some of its directors are interested, purchased 70,251 shares at a price of 2,122 pence per share on Thursday.

Chairman and Chief Executive Said Darwazah is a shareholder in Darhold with an equity interest of 21.49%, Executive Vice Chairman Mazen Darwazah holds a 10.82% stake and Non-Executive Director Mohammed Al-Husry has a 7.95% stake. All three are directors of Darhold.

Hikma did not reveal the stake held by the three directors or Darhold after the transaction.

The stock closed down 0.4% to 2,133.00 pence per share on Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Related Shares

More News

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 10:15

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

25 Apr 2024 08:01

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...